Company / Net Debt per Share
Kura Oncology, Inc. Net Debt per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$1.78
FY2025
5-year range
-$2.89 / -$0.38
FY2021-FY2025
Trend
+38.4%
vs FY2024
Sector context
#65 of 82
Health Care
What the data says
Kura Oncology, Inc.'s net debt per share of $-1.78 is lower than 79% of companies in the Health Care sector (FY2025). Net Debt per Share has fluctuated over the past 9 years, ranging from $-6.05 in FY2020 to $-0.13 in FY2016.
Based on SEC 10-K filings.
-1.78 in FY2025.
Improved from $-0.38 to $-1.78 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 82This company -$1.78 Sector average $13.70
▼
-113.0% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 38.4% year-over-year.
- Ranks #65 out of 82 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2016.
- Lowest net debt per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.83 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.78 | +38.4% |
| FY2024 | -$2.89 | -656.4% |
| FY2023 | -$0.38 | +40.0% |
| FY2022 | -$0.64 | - |
| FY2021 | - | - |
| FY2020 | -$6.05 | -1244.3% |
| FY2019 | -$0.45 | -83.8% |
| FY2018 | -$0.24 | +3.0% |
| FY2017 | -$0.25 | -96.6% |
| FY2016 | -$0.13 | - |
As of FY2025 · SEC 10-K · Updated Mar 28, 2026